KATP channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia

Journal of the American College of Cardiology

Volumn 40, Issue 7, 2002, Pages 1339-1346

  Genda, Satoshi ^a   Miura, Tetsuji ^a,b   Miki, Takayuki ^a   Ichikawa, Yoshihiko ^a   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADENOSINE TRIPHOSPHATE; EVANS BLUE; GLIBENCLAMIDE; N(G) METHYLARGININE; NICORANDIL; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; TETRAZOLIUM; THIOFLAVINE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CHOLESTEROL DIET; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; HEART INFARCTION SIZE; HYPERCHOLESTEROLEMIA; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; WOUND HEALING IMPAIRMENT;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; CHRONIC DISEASE; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; GLYBURIDE; HEMODYNAMIC PROCESSES; HYPERCHOLESTEROLEMIA; MALE; MYOCARDIAL INFARCTION; NICORANDIL; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RABBITS; VASODILATOR AGENTS;

EID: 0037009978     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02156-3     Document Type: Article

References (27)

1. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54: 1496-508.
2. Endoh A, Miura T, Iimura O. Does delayed no-reflow phenomenon cause myocardial necrosis? J Cardiovasc Pathol 1993;2:225-30.
3. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no-reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
4. Asanuma T, Tanabe K, Ochiai K, et al. Relationship between progressive microvascular damage and intramyocardial hemorrhage in patients with reperfused anterior myocardial infarction. Myocardial contrast echocardiographic study. Circulation 1997;96:448-53.
5. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
6. Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999;33:654-60.
7. Gerber BL, Rochitte CE, Melin JA, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000;101:2734-41.
8. Engler RL, Schmid-Schönbein GW, Pavelec RS. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983;111:98-111.
9. Humphrey SM, Gavin JB, Herdson PB. The relationship of ischemic contracture to vascular reperfusion in the isolated rat heart. J Mol Cell Cardiol 1980;12:1397-406.
10. Manciet LH, Poole DC, McDonagh PF, Copeland JG, Mathieu-Costello M. Microvascular compression during myocardial ischemia: mechanistic basis for no-reflow phenomenon. Am J Physiol 1994;266: H1541-50.
11. ATP channel openers. Trend Pharmacol Sci 2000;21:439-45
12. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991;83:652-60.
13. + channels. Circ Res 1997;80:1-10.
14. Tanikawa T, Kanatsuka H, Koshida R, et al. Role of pertussis toxin-sensitive G protein in metabolic vasodilation of coronary circulation. Am J Physiol 2000;279:H1819-29.
15. Miura T, Shizukuda Y, Ogawa S, et al. Effects of early and later reperfusion on healing speed of experimental myocardial infarct. Can J Cardiol 1991;7:146-54.
16. Shizukuda Y, Miura T, Ishimoto R, Itoya M, Iimura O. Effect of prednisolone on myocardial infarct healing: characteristics and comparison with indomethacin. Can J Cardiol 1991;7:447-54.
17. ATP channel occurs downstream of PKC-ε activation in the mechanism of preconditioning. Am J Physiol 2002;283:H440-7.
18. Komaru T, Lamping KG, Eastham CL, Dellsperger KC. Role of ATP-sensitive potassium channels in coronary microvascular autoregulatory responses. Circ Res 1991;69:1146-51.
19. Golino P, Maroko PR, Carew TE. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion. Circulation 1987;75:292-8.
20. Golino P, Maroko PR, Carew TE. Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occluslon-reperfusion. Circulation 1987;76:173-80.
21. Pongo E, Balla Z, Mubagwa K, et al. Deterioration of the protein kinase C-KATP channel pathway in regulation of coronary flow in hypercholesterolemic rabbits. Eur J Pharmacol 2001;418:217-23.
22. + channel-mediated vasodilatation in vivo. Am J Physiol 2000;279:H1600-8.
23. + channels regulates coronary blood flow in ischemic myocardium. Circulation 1997;95:1560-7.
24. Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol 1997;30:1193-9.
25. Kloner PA, Rude RE, Carlson N, et al. Ultrastructural evidence of microvascular damage and myocardial cell injury after coronary artery occlusion: Which comes first? Circulation 1980;62:945-52.
26. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol 2001;12:383-9
27. Tracy RE. Medial thickenings of coronary artery and the aging risk factor for atherosclerosis. Atherosclerosis 2001;155:337-46.